VRCA
Asset Logo

VERRICA PHARMACEUTICALS INC

πŸ‡ΊπŸ‡Έ NYSE/NASDAQ

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸƒ Esg

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-18.65%
Annual Growth

5 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. The Company is focused on developing and commercializing treatments for skin diseases. Its product pipeline consists of three product candidates: YCANTH, VP-315 and VP-103. YCANTH is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. We are also developing YCANTH for potential follow-on indications for the treatment of common warts and external genital warts. In addition, the Company is also developing YCANTH for the treatment of external genital warts, or external genital warts EGW. Its second candidate, VP-315, is an oncolytic peptide-based injectable therapy for the potential treatment of dermatology oncologic conditions, including basal cell carcinoma, non-metastatic melanoma, and non-metastatic Merkel cell carcinoma. VP-103, a second cantharidin based drug device combination for the potential treatment of plantar warts.

πŸ“ˆ Performance

Price History*

-94.31%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$1.00

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in VRCA

1

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

70 weeks

πŸ’΅ Average investment amount

$54

⏰ Last time a customer invested in VRCA

471 days
VRCA investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

100%

50k - 100k

Less than 50k

πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

100%
πŸ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in VRCA also invest in...

Apple, Inc.

AAPL

πŸ™Œ Performance (5Yr p.a)

50.23%

πŸ“Š Share price

$229.87 USD

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

πŸ™Œ Performance (5Yr p.a)

-8.66%

πŸ“Š Share price

$4.22 USD

πŸ™Œ Performance (5Yr p.a)

10.79%

πŸ“Š Share price

$180.08 USD

πŸ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

πŸ™Œ Performance (5Yr p.a)

23.43%

πŸ“Š Share price

$20.20 USD

πŸ“ˆ HIGH PRICE GROWTH

πŸ™Œ Performance (5Yr p.a)

-19.94%

πŸ“Š Share price

$0.01 USD
Compare
Add to watchlist